Development of the selective progesterone receptor modulator CDB-2914 for clinical indications (Q34543824)

2 August 2017

Development of the selective progesterone receptor modulator CDB-2914 for clinical indications (English)

1 reference

2 August 2017

1 reference

1 reference

2

Lynnette K Nieman

1 reference

2 August 2017

Diana L Blithe

1

1 reference

2 August 2017

Richard P Blye

series ordinal

3

1 reference

2 August 2017

Pamela Stratton

series ordinal

4

1 reference

2 August 2017

Maureen Passaro

series ordinal

5

1 reference

2 August 2017

1 November 2003

1 reference

2 August 2017

1 reference

2 August 2017

68

1 reference

2 August 2017

10-13

1 reference

2 August 2017

1013-1017

1 reference

CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Effect of long-term treatment with low-dose mifepristone on the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Low-dose mifepristone for uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Antiovulatory and postcoital antifertility activity of the antiprogestin CDB-2914 when administered as single, multiple, or continuous doses to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

To what extent do oral contraceptives influence mood and affect?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

Follicle stimulating hormone-granulosa cell axis involvement in the antifolliculotrophic effect of low dose mifepristone (RU486)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900118-1

7 January 2021

10.1016/S0039-128X(03)00118-1

Identifiers

DOI

1 reference

2 August 2017

1 reference